Keto Diet And Apoe4 Gene: Does It Work?

The ketogenic diet is a low-carbohydrate, high-fat diet that has been used to treat drug-resistant epilepsy and is being studied for its potential to prevent or treat Alzheimer's disease. The diet involves eating large amounts of fat to shift the body from burning glucose to burning ketones, which are produced when the body burns fat.

The APOE4 gene variant is a risk factor for late-onset Alzheimer's disease and affects fat metabolism and distribution to the brain. While the ketogenic diet has been shown to improve cognition in Alzheimer's patients, its effects on APOE4 carriers are less clear. Some studies suggest that APOE4 carriers may not experience the same benefits as non-carriers and that a ketogenic diet high in saturated fat could even increase their risk of developing Alzheimer's. However, other sources suggest that a ketogenic diet may be beneficial for APOE4 carriers experiencing cognitive decline or Alzheimer's.

Overall, more research is needed to determine the effects of a ketogenic diet on APOE4 carriers, particularly in the context of Alzheimer's disease prevention.

Ketogenic diets may improve cognition in ApoE4+ patients with mild Alzheimer's disease

It has been established that there is a correlation between Alzheimer's disease and apolipoprotein E, specifically the ApoE4 genetic variant. Individuals with the ApoE4 allele variant, also known as the Alzheimer's disease gene, are primarily at a greater risk for physiological consequences, specifically cognitive impairment.

Case Study

In a 2019 case study, a 71-year-old female with a family history of Alzheimer's disease and a dual diagnosis of mild Alzheimer's disease and metabolic syndrome was placed on a 10-week nutrition protocol designed to raise plasma ketones through a carbohydrate-restricted, high-fat ketogenic diet, time-restricted eating, and physical/cognitive exercise.

Results

The results of the case study were statistically significant, with improvements in biomarkers for metabolic syndrome and cognition. The baseline MoCA (Montreal Cognitive Assessment) score was 21/30, and the post-treatment score was 28/30.

The significant results in both metabolic syndrome biomarkers and the MoCA score suggest that a ketogenic diet may serve to rescue cognition in patients with mild Alzheimer's disease. The results are particularly compelling for ApoE4-positive subjects, as ketogenic protocols extend hope and promise for Alzheimer's disease prevention.

Considerations for APOE4 Carriers

It is recommended that individuals with the APOE4 genotype take a more liberalized version of the ketogenic diet and gradually restrict carbohydrates while monitoring biomarkers for adverse reactions. It may also be beneficial to incorporate fiber-rich vegetables and choose unsaturated rather than saturated fats.

APOE4 carriers may benefit from a ketogenic diet once Alzheimer's is already present

A ketogenic diet may be beneficial for APOE4 carriers who already have Alzheimer's disease. This is because a ketogenic diet can improve cognition in APOE4 carriers with mild Alzheimer's disease. In one study, a 71-year-old female APOE4 carrier with a family history of Alzheimer's and a dual diagnosis of mild Alzheimer's and metabolic syndrome was placed on a 10-week nutrition protocol. This protocol involved a carbohydrate-restricted, high-fat ketogenic diet, time-restricted eating, and physical and cognitive exercise. The results showed a significant improvement in both metabolic syndrome biomarkers and cognitive performance.

The potential benefits of a ketogenic diet for APOE4 carriers with Alzheimer's may be due to the diet's impact on various biological mechanisms. For example, a ketogenic diet can:

• Improve insulin sensitivity and reduce insulin resistance, which is a central feature of Alzheimer's.
• Reduce inflammation, oxidative stress, and mitochondrial dysfunction, which are basic metabolic pathologies that contribute to Alzheimer's.
• Protect against lipotoxicity in neurons and provide an alternative source of acetyl-CoA, which is important for energy metabolism in the brain.
• Inhibit the formation of the NLRP3 inflammasome, which plays a critical role in the development of Alzheimer's.
• Improve cerebral blood flow, which is especially important for APOE4 carriers.

However, it is important to note that the effectiveness of a ketogenic diet in preventing Alzheimer's in APOE4 carriers is still unclear. Some studies suggest that APOE4 carriers do not experience the same cognitive benefits from a ketogenic diet as non-carriers. Additionally, there are potential health risks associated with high-fat, low-carb diets, such as elevated LDL cholesterol and other blood lipids, which may increase the risk of Alzheimer's or associated disorders.

Therefore, while a ketogenic diet may be beneficial for APOE4 carriers who already have Alzheimer's disease, it is not recommended as a preventive strategy for carriers who do not yet have the disease. More research is needed to determine the long-term effects of a ketogenic diet on APOE4 carriers, both with and without Alzheimer's disease.

APOE4 carriers should avoid a ketogenic diet as a preventative measure

The APOE4 gene variant is a risk factor for late-onset Alzheimer's disease, affecting fat metabolism and distribution to the brain. While a ketogenic diet may be beneficial for those already suffering from Alzheimer's disease, it is likely a poor strategy for preventing the disease in APOE4 carriers.

Alzheimer's and Glucose Metabolism in the Brain

The hypothesis that Alzheimer's is driven by a disruption of glucose metabolism in the brain has been supported by numerous studies reporting slowed glucose metabolism in individuals with the disease. However, it is unclear whether Alzheimer's leads to a reduced requirement for glucose in the brain, or if a reduction in glucose metabolism leads to the development of Alzheimer's.

Ketogenic Diet and Alzheimer's Studies

Ketogenic diets have been the subject of several studies investigating their effect on Alzheimer's models. While some studies have shown positive effects, such as a protective effect against a fragment of the amyloid precursor protein, the overall evidence suggests that APOE4 carriers do not benefit from a ketogenic diet as a preventative measure.

LDL Cholesterol and Blood Lipids

Elevated LDL cholesterol and other blood lipids may be associated with an increased risk of developing Alzheimer's or associated disorders. A ketogenic diet could negatively impact these lipid markers, potentially increasing the risk for APOE4 carriers.

Alternative Approaches for APOE4 Carriers

Instead of a ketogenic diet, APOE4 carriers should focus on a diet that is moderate in fat, moderate in protein, and includes plant-based fiber. Monounsaturated fatty acids, such as avocados, nuts, and olive oil, are preferable to saturated fats.

In addition to dietary modifications, APOE4 carriers can support their brain health through regular exercise, sleep, socialising, and engaging their brain in new ways.

APOE4 carriers should limit alcohol consumption

APOE4 carriers are at a higher risk of developing Alzheimer's disease. The APOE4 gene variant affects fat metabolism and distribution to the brain. It is important to note that the effects of alcohol consumption on health are not entirely clear, with some studies showing benefits and others showing harm. However, when it comes to APOE4 carriers, research suggests that alcohol consumption may be damaging and that the best strategy for these individuals may be to avoid alcohol entirely.

Light to moderate alcohol consumption has been found to reduce the risk of Alzheimer's disease in the general population. However, this relationship does not seem to hold for APOE4 carriers. Studies have shown that even a small amount of alcohol consumption may increase the risk of Alzheimer's disease in APOE4 carriers.

One study found that APOE4 carriers who consumed alcohol one or more times per month had a higher risk of Alzheimer's disease than those who never consumed alcohol. Another study found that light and moderate alcohol consumption during late life was associated with greater decline in learning and memory among APOE4 carriers, while it was associated with an increase in learning and memory among non-carriers.

The exact mechanisms behind the link between alcohol consumption and Alzheimer's disease risk in APOE4 carriers are not yet fully understood, but it appears that alcohol may have neurotoxic effects and disrupt sleep, which could contribute to amyloid plaque build-up in the brain.

It is important to note that these findings are based on observational studies, and more research is needed to establish a causal relationship. However, given the potential risks, it may be prudent for APOE4 carriers to limit or avoid alcohol consumption as a precautionary measure.

APOE4 carriers should avoid saturated and trans fats

The APOE gene comes in three types: APOE2, APOE3, and APOE4. Each person carries two types of the APOE gene, which provide instructions for the body on how to make apolipoprotein E, which combines with fats to form lipoproteins.

The APOE4 gene is a risk factor for late-onset Alzheimer's disease and affects fat metabolism and distribution to the brain. Carriers of the APOE4 gene are most affected by high cholesterol and benefit more from a low-saturated-fat, low-carb diet, instead using monounsaturated fats.

Research has shown that a high-fat, very-low-carbohydrate ketogenic diet did not affect hippocampal levels of APOE in mice. However, a high-fat diet did reduce APOE levels in the hippocampus of APOE3 carriers, but caused no change in APOE4 carriers.

A case study on a 71-year-old female APOE4 carrier with mild Alzheimer's disease showed that a 10-week nutrition protocol of a high-fat, carbohydrate-restricted, ketogenic diet, time-restricted eating, and physical/cognitive exercise resulted in statistically significant improvements in biomarkers for metabolic syndrome and the Montreal Cognitive Assessment score.

Dr. Dominic D'Agostino, however, questions whether a high-fat ketogenic diet is suitable for people carrying an APOE4 gene variant. He suggests a more liberalized version of the diet, gradually restricting carbohydrates, and monitoring biomarkers for adverse reactions. He also recommends incorporating fiber-rich vegetables and choosing unsaturated rather than saturated fats.

Therefore, while there is some evidence that a ketogenic diet may be beneficial for APOE4 carriers with Alzheimer's disease, more research is needed to determine the long-term effects of a high-fat ketogenic diet on APOE4 carriers.

Frequently asked questions